Trace elements in serum from patients with Parkinson's disease - a prospective case-control study. The Nord-Trøndelag Health Study (HUNT)

Brain Research

Volumn 1219, Issue , 2008, Pages 111-115

  Gellein, Kristin ^a   Syversen, Tore ^a   Steinnes, Eiliv ^a   Nilsen, Tom Ivar Lund ^a   Dahl, Ole Petter ^b   Mitrovic, Sascha ^c   Duraj, Dusan ^d   Flaten, Trond Peder ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b Hospital Namsos   (Norway)

^c Levanger Hospital   (Norway)

^d Nevrolog Duraj AS   (Norway)

Author keywords

Epidemiology; Parkinson's disease; Prospective case control study; Trace element

Indexed keywords

ARSENIC; CALCIUM; CHROMIUM; COBALT; COPPER; IRON; LEAD; MAGNESIUM; MANGANESE; MERCURY; MOLYBDENUM; NICKEL; RUBIDIUM; SELENIUM; STRONTIUM; THALLIUM; TRACE ELEMENT; URANIUM; YTTRIUM; ZINC;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MASS SPECTROMETRY; PARKINSON DISEASE; PRIORITY JOURNAL; TRACE METAL BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NORWAY; PARKINSON DISEASE; RETROSPECTIVE STUDIES; TRACE ELEMENTS;

EID: 45849139676     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.05.002     Document Type: Article

References (25)

1. Aschner M., and Aschner J.L. Mercury neurotoxicity: mechanisms of blood-brain barrier transport. Neurosci. Biobehav. Rev. 14 (1990) 169-176
2. Bocca B., Alimonti A., Petrucci F., Violante N., Sancesario G., Forte G., and Senofonte O. Quantification of trace elements by sector field inductively coupled plasma mass spectrometry in urine, serum, blood and cerebrospinal fluid of patients with Parkinson's disease. Spectrochim. Acta B 59 (2004) 559-566
3. Calne D.B., Chu N.S., Huang C.C., Lu C.S., and Olanow W. Manganism and idiopathic parkinsonism: similarities and differences. Neurology 44 (1994) 1583-1586
4. Campbell A., Smith M.A., Sayre L.M., Bondy S.C., and Perry G. Mechanisms by which metals promote events connected to neurodegenerative diseases. Brain Res. Bull. 55 (2001) 125-132
5. de Lau L.M.L., and Breteler M.M.B. Epidemiology of Parkinson's disease. Lancet Neurol. 5 (2006) 525-535
6. Forte G., Bocca B., Senofonte O., Petrucci F., Brusa L., Stanzione P., Zannino S., Violante N., Alimonti A., and Sancesario G. Trace and major elements in whole blood, serum, cerebrospinal fluid and urine of patients with Parkinson's disease. J. Neural Transm. 111 (2004) 1031-1040
7. Forte G., Alimonti A., Pino A., Stanzione P., Brescianini S., Brusa L., Sancesario G., Violante N., and Bocca B. Metals and oxidative stress in patients with Parkinson's disease. Ann. Ist. Super. Sanita 41 (2005) 189-195
8. Gaggelli E., Kozlowski H., Valensin D., and Valensin G. Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis). Chem. Rev. 106 (2006) 1995-2044
9. Garruto R.M. Pacific paradigms of environmentally-induced neurological disorders: clinical, epidemiological and molecular perspectives. Neurotoxicology 12 (1991) 347-377
10. Gerlach M., Ben-Shachar D., Riederer P., and Youdim M.B.H. Altered brain metabolism of iron as a cause of neurodegenerative diseases?. J. Neurochem. 63 (1994) 793-807
11. Gorell J.M., Peterson E.L., Rybicki B.A., and Johnson C.C. Multiple risk factors for Parkinson's disease. J. Neurol. Sci. 217 (2004) 169-174
12. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J. Neurochem. 97 (2006) 1634-1658
13. Hegde M.L., Shanmugavelu P., Vengamma B., Sathyanarayana Rao T.S., Menon R.B., Rao R.V., and Jagannatha Rao K.S. Serum trace element levels and the complexity of inter-element relations in patients with Parkinson's disease. J. Trace Elem. Med. Biol. 18 (2004) 163-171
14. Holmen J., Midthjell K., Krüger Ø., Langhammer A., Holmen T.L., Bratberg G.H., Vatten L., and Lund-Larsen P.G. The Nord-Trøndelag Health Study 1995-97 (HUNT 2): objectives, contents, methods and participation. Norsk Epidemiologi 13 (2003) 19-32
15. Hughes A.J., Daniel S.E., Kilford L., and Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55 (1992) 181-184
16. Jiménez-Jiménes F.J., Fernández-Calle P., Martínez-Vanaclocha M., Herrero E., Molina J.A., Vázquez A., and Codoceo R. Serum levels of zinc and copper in patients with Parkinson's disease. J. Neurol. Sci. 112 (1992) 30-33
17. Jiménez-Jiménez F.J., Molina J.A., Aguilar M.V., Arrieta F.J., Jorge-Santamaría A., Cabrera-Valdivia F., Ayuso-Peralta L., Rabasa M., Vázquez A., García-Albea E., and Martínez-Para M.C. Serum and urinary manganese levels in patients with Parkinson's disease. Acta Neurol. Scand. 91 (1995) 317-320
18. Pino A., Brescianini S., D'Ippolito C., Fagnani C., Alimonti A., and Stazi M.A. Discriminant analysis to study trace elements in biomonitoring: an application on neurodegenerative diseases. Ann. Ist. Super. Sanita 41 (2005) 223-228
19. Powers K.M., Smith-Weller T., Franklin G.M., Longstreth Jr. W.T., Swanson P.D., and Checkoway H. Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes. Neurology 60 (2003) 1761-1766
20. Riederer P., Sofic E., Rausch W.-D., Schmidt B., Reynolds G.P., Jellinger K., and Youdim M.B.H. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J. Neurochem. 52 (1989) 515-520
21. Samii A., Nutt J.G., and Ransom B.R. Parkinson's disease. Lancet 363 (2004) 1783-1793
22. Sayre L.M., Perry G., and Smith M.A. Redox metals and neurodegenerative disease. Curr. Opin. Chem. Biol. 3 (1999) 220-225
23. Schweizer U., Bräuer A.U., Köhrle J., Nitsch R., and Savaskan N.E. Selenium and brain function: a poorly recognized liaison. Brain Res. Rev. 45 (2004) 164-178
24. Versieck J., and Cornelis R. Trace Elements in Human Plasma or Serum (1989), CRC Press, Boca Raton
25. Yasui M., Kihira T., and Ota K. Calcium, magnesium and aluminum concentrations in Parkinson's disease. Neurotoxicology 13 (1992) 593-600